9926.HK
Price:
$115.2
Market Cap:
$93.48B
Akeso, Inc., a biopharmaceutical company, researches, develops, manufactures, and commercializes therapies. The company develops AK104, a PD-1/CTLA-4 bi-specific antibody to treat cervical cancer, gastric cancer (GC), gastroesophageal junction (GEJ) adenocarcinoma, hepatocellular carcinoma (HCC), non-small cell lung cancer (NSCLC), small cell lung cancer (SCLC), nasopharyngeal carcinoma (NPC), clear cell renal cell carcinoma, and solid tumors; and AK112, a PD-1/VEGF bi-specific antibody to treat solid and gynecological tumors, NSCLC, SCLC, and triple-negative breast cancer (TNBC). It is also developing AK105, a PD-1 monoclonal antibody to treat NSCLC, NPC, classic Hodgkin's lymphoma (R/R cHL...[Read more]
Industry
Biotechnology
IPO Date
2020-04-24
Stock Exchange
HKSE
Ticker
9926.HK
According to Akeso, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 91.43B. This represents a change of 100.12% compared to the average of 45.69B of the last 4 quarters.
The mean historical Enterprise Value of Akeso, Inc. over the last ten years is 23.80B. The current 91.43B Enterprise Value has changed 38.32% with respect to the historical average. Over the past ten years (40 quarters), 9926.HK's Enterprise Value was at its highest in in the June 2025 quarter at 72.66B. The Enterprise Value was at its lowest in in the June 2019 quarter at -139620553.78.
Average
23.80B
Median
20.81B
Minimum
1.20B
Maximum
45.58B
Discovering the peaks and valleys of Akeso, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.37%
Maximum Annual Enterprise Value = 45.58B
Minimum Annual Increase = -92.50%
Minimum Annual Enterprise Value = 1.20B
| Year | Enterprise Value | Change |
|---|---|---|
| 2024 | 45.58B | 33.37% |
| 2023 | 34.17B | 9.84% |
| 2022 | 31.11B | 49.49% |
| 2021 | 20.81B | 17.75% |
| 2020 | 17.67B | 1.37% |
| 2019 | 1.20B | -92.50% |
The current Enterprise Value of Akeso, Inc. (9926.HK) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
36.95B
5-year avg
29.87B
10-year avg
23.80B
Akeso, Inc.’s Enterprise Value is less than Sino Biopharmaceutical Limited (106.59B), greater than 3SBio Inc. (56.98B), less than TransThera Sciences (Nanjing) Inc. (0), less than Innovent Biologics, Inc. (121.09B), less than WuXi Biologics (Cayman) Inc. (118.56B), greater than RemeGen Co., Ltd. (44.50B), greater than Alibaba Health Information Technology Limited (72.00B), greater than InnoCare Pharma Limited (12.11B), greater than CSPC Pharmaceutical Group Limited (78.11B), greater than Shanghai Junshi Biosciences Co., Ltd. (35.39B),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 106.59B | $116.97B | |
| 56.98B | $62.87B | |
| 0 | $66.96B | |
| 121.09B | $140.76B | |
| 118.56B | $134.84B | |
| 44.50B | $41.43B | |
| 72.00B | $85.01B | |
| 12.11B | $19.63B | |
| 78.11B | $94.24B | |
| 35.39B | $32.53B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Akeso, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Akeso, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Akeso, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Akeso, Inc. (9926.HK)?
What is the 3-year average Enterprise Value for Akeso, Inc. (9926.HK)?
What is the 5-year average Enterprise Value for Akeso, Inc. (9926.HK)?
How does the current Enterprise Value for Akeso, Inc. (9926.HK) compare to its historical average?